Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks
- Publikationstyp:
- Konferenzbeitrag
- Metadaten:
-
- Autoren
- T Schirmeister
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000080838300010&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1002/(SICI)1097-0282(1999)51:1<87::AID-BIP10>3.0.CO;2-Z
- Externe Identifier
- Clarivate Analytics Document Solution ID: 205UE
- PubMed Identifier: 10380356
- ISSN
- 0006-3525
- Ausgabe der Veröffentlichung
- 1
- Zeitschrift
- BIOPOLYMERS
- Schlüsselwörter
- inhibition
- cysteine proteases
- aziridine-2,3-dicarboxylic acid
- building blocks
- degradation of proteins
- Paginierung
- 87 - 97
- Datum der Veröffentlichung
- 1999
- Status
- Published
- Titel
- Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks
- Ausgabe der Zeitschrift
- 51
Datenquelle: Web of Science (Lite)
- Andere Metadatenquellen:
-
- Autoren
- Tanja Schirmeister
- DOI
- 10.1002/(sici)1097-0282(1999)51:1<87::aid-bip10>3.0.co;2-z
- eISSN
- 1097-0282
- ISSN
- 0006-3525
- Ausgabe der Veröffentlichung
- 1
- Zeitschrift
- Biopolymers
- Paginierung
- 87 - 97
- Datum der Veröffentlichung
- 1999
- Status
- Published
- Herausgeber
- Wiley
- Herausgeber URL
- http://dx.doi.org/10.1002/(sici)1097-0282(1999)51:1%3C87::aid-bip10%3E3.0.co;2-z
- Datum der Datenerfassung
- 2021
- Titel
- Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks
- Ausgabe der Zeitschrift
- 51
Datenquelle: Crossref
- Abstract
- Mammalian cysteine proteases of the papain superfamily are interesting targets for the development of new drugs against diseases connected to abnormal degradation of muscle or bone proteins. The high nucleophilicity of the active site of these proteases as well as the characteristics of the well-known epoxysuccinic acid derived cysteine protease inhibitors provided a basis for the design of new types of selective and irreversible inhibitors for these enzymes. We designed and synthesized a novel class of peptidic cysteine protease inhibitors containing aziridine-2,3-dicarboxylic acid as electrophilic amino acid. Three types of aziridinyl peptides that differ in the position of the aziridine building block within the peptide chain have been synthesized and tested as inhibitors of several cysteine proteases. Remarkable differences could be observed between the three types of inhibitors concerning their activity, stereospecificity, pH dependency of inhibition, and selectivity between different cysteine proteases, respectively, indicating that different binding modes of the three types of inhibitors in respect to their orientation in the S and S' binding sites of the enzymes may be present.
- Addresses
- Department of Pharmaceutical Chemistry, Albert-Ludwigs University of Freiburg, Germany.
- Autoren
- T Schirmeister
- DOI
- 10.1002/(sici)1097-0282(1999)51:1<87::aid-bip10>3.0.co;2-z
- eISSN
- 1097-0282
- Externe Identifier
- PubMed Identifier: 10380356
- Open access
- false
- ISSN
- 0006-3525
- Ausgabe der Veröffentlichung
- 1
- Zeitschrift
- Biopolymers
- Schlüsselwörter
- Humans
- Bone Diseases
- Muscular Diseases
- Dicarboxylic Acids
- Aziridines
- Cathepsins
- Papain
- Oligopeptides
- Cysteine Proteinase Inhibitors
- Structure-Activity Relationship
- Substrate Specificity
- Drug Design
- Medium
- Paginierung
- 87 - 97
- Datum der Veröffentlichung
- 1999
- Status
- Published
- Datum der Datenerfassung
- 1999
- Titel
- Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks.
- Ausgabe der Zeitschrift
- 51
Datenquelle: Europe PubMed Central
- Abstract
- Mammalian cysteine proteases of the papain superfamily are interesting targets for the development of new drugs against diseases connected to abnormal degradation of muscle or bone proteins. The high nucleophilicity of the active site of these proteases as well as the characteristics of the well-known epoxysuccinic acid derived cysteine protease inhibitors provided a basis for the design of new types of selective and irreversible inhibitors for these enzymes. We designed and synthesized a novel class of peptidic cysteine protease inhibitors containing aziridine-2,3-dicarboxylic acid as electrophilic amino acid. Three types of aziridinyl peptides that differ in the position of the aziridine building block within the peptide chain have been synthesized and tested as inhibitors of several cysteine proteases. Remarkable differences could be observed between the three types of inhibitors concerning their activity, stereospecificity, pH dependency of inhibition, and selectivity between different cysteine proteases, respectively, indicating that different binding modes of the three types of inhibitors in respect to their orientation in the S and S' binding sites of the enzymes may be present.
- Autoren
- T Schirmeister
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/10380356
- DOI
- 10.1002/(SICI)1097-0282(1999)51:1<87::AID-BIP10>3.0.CO;2-Z
- ISSN
- 0006-3525
- Ausgabe der Veröffentlichung
- 1
- Zeitschrift
- Biopolymers
- Schlüsselwörter
- Aziridines
- Bone Diseases
- Cathepsins
- Cysteine Proteinase Inhibitors
- Dicarboxylic Acids
- Drug Design
- Humans
- Muscular Diseases
- Oligopeptides
- Papain
- Structure-Activity Relationship
- Substrate Specificity
- Conference place
- United States
- Paginierung
- 87 - 97
- Datum der Veröffentlichung
- 1999
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 1999
- Titel
- Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks.
- Ausgabe der Zeitschrift
- 51
Datenquelle: PubMed
- Beziehungen:
- Eigentum von